-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q2 2010 to Q2 2024.
- Elite Pharmaceuticals Inc /Nv/ Depreciation, Depletion and Amortization for the quarter ending June 30, 2024 was $322K, a 1.88% decline year-over-year.
- Elite Pharmaceuticals Inc /Nv/ annual Depreciation, Depletion and Amortization for 2023 was $1.32M, a 3.36% increase from 2022.
- Elite Pharmaceuticals Inc /Nv/ annual Depreciation, Depletion and Amortization for 2022 was $1.28M, a 5.67% increase from 2021.
- Elite Pharmaceuticals Inc /Nv/ annual Depreciation, Depletion and Amortization for 2021 was $1.21M, a 7.97% decline from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)